REQUEST A DEMO
Total
USD $0.00
Search more companies

Baanmorya Pharma Company Limited (Thailand)

Main Activities: Pharmacies and Drug Stores
Full name: Baanmorya Pharma Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Baanmorya Pharma Company Limited is a company based in Thailand, with its head office in Ratchaburi. The company operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on July 06, 2026. There are currently 12 (estimated) people employed by Baanmorya Pharma Company Limited. From the latest financial highlights, Baanmorya Pharma Company Limited reported a net sales revenue increase of 18.07% in 2025. A growth of 5.28% was recorded in its total assets. The net profit margin of Baanmorya Pharma Company Limited decreased by 0.32% in 2025.

Headquarters
102/1 Moo 6
Ratchaburi; Western Thailand; Postal Code: 70120

Contact Details: Purchase the Baanmorya Pharma Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Baanmorya Pharma Company Limited report to view the information.
Financial Auditors:
Purchase the Baanmorya Pharma Company Limited report to view the information.
Incorporation Date:
July 06, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Baanmorya Pharma Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
18.07%
Total Operating Revenue
18.07%
Operating Profit
-36.48%
Net Profit/Loss for the Period
-41.45%
Total Assets
5.28%
Total Equity
3.69%
Operating Profit Margin
-0.38%
Net Profit Margin
-0.32%
Return on Equity (ROE)
-2.75%
Debt / Equity
6.69%
Quick Ratio
-31.29%
Cash Ratio
-29.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?